Abstract

Dyskeratosis congenita (DC) is a progressive and heterogeneous congenital disorder that affects multiple systems and is characterized by bone marrow failure and a triad of abnormal skin pigmentation, nail dystrophy, and oral leukoplakia. One common feature for all DC patients is abnormally short telomeres and defects in telomere biology. Most of the known DC mutations have been found to affect core components of the telomerase holoenzyme. Recently, multiple mutations in the gene encoding the telomeric protein TIN2 have been identified in DC patients with intact telomerase genes, but the molecular mechanisms underlying TIN2 mutation-mediated DC remain unknown. Here, we demonstrate that ectopic expression of TIN2 with DC missense mutations in human cells led to accelerated telomere shortening, similar to the telomere phenotypes found in DC patients. However, this telomere shortening was not accompanied by changes in total telomerase activity, localization of TIN2, or telomere end protection status. Interestingly, we found TIN2 to participate in the TPP1-dependent recruitment of telomerase activity. Furthermore, DC mutations in TIN2 led to its decreased ability to associate with TERC and telomerase activity. Taken together, our data suggest that TIN2 mutations in DC may compromise the telomere recruitment of telomerase, leading to telomere shortening and the associated pathogenesis.

Highlights

  • Genetic heterogeneity exists, where mutations have been identified in genes encoding various subunits of the telomerase holoenzyme, including TERC, TERT, DKC1, NOP10, and NHP2 [5, 9, 11,12,13,14]

  • We found no significant increase in cells containing telomere dysfunction-induced foci when mutant TIN2 expression was induced (Fig. 3E), indicating that Dyskeratosis congenita (DC) mutations have minimal impact on TIN2-mediated telomere protection and are unlikely to disrupt TIN2 interaction with other core telomeric proteins

  • We investigated the mechanism by which DC missense mutants of TIN2 could trigger telomere shortening

Read more

Summary

Introduction

Genetic heterogeneity exists, where mutations have been identified in genes encoding various subunits of the telomerase holoenzyme, including TERC, TERT, DKC1, NOP10, and NHP2 [5, 9, 11,12,13,14]. Using telomerase-positive human cells that ectopically expressed TIN2 mutants, we recapitulated the telomere shortening observed in DC patients and provided the potential links between such defects and the recruitment of telomerase. TRF Assay—HTC75 cells stably expressing control and FLAG-tagged wild-type and mutant TIN2 proteins were generated and passaged for TRF analysis as described previously [32].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call